8-K 1 a4439669.txt DIAGNOSTIC PRODCUTS 8-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) JULY 23, 2003_ --------------- Diagnostic Products Corporation ------------------------------- (Exact name of Registrant as specified in its charter) California 1-9957 95-2802182 ---------- ------ ---------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 5700 West 96th Street, Los Angeles, California 90045 ---------------------------------------------------- (Address of principal executive offices) (Zip Code) (310) 645-8200 (Registrant's telephone number, including area code) Diagnostic Products Corporation Current Report on Form 8-K ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. No. 99.1 Press Release issued by Diagnostic Products Corporation, dated July 23, 2003. ITEM 9. REGULATION FD DISCLOSURE. The information required by ITEM 12, RESULTS OF OPERATIONS AND FINANCIAL CONDITION, of Form 8-K is being furnished in this ITEM 9 in accordance with interim guidance of the SEC. On July 23, 2003, Diagnostic Products Corporation announced its results of operations for the quarter ended June 30, 2003. A copy of the related press release is being furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 23, 2003 Diagnostic Products Corporation By: /S/ James L. Brill -------------------------------------- James L. Brill, Vice President, Finance EXHIBIT INDEX Exhibit Number -------------- 99.1 Press Release issued by Diagnostic Products Corporation, dated July 23, 2003.